Detalhe da pesquisa
1.
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Lancet Oncol
; 23(8): 1066-1077, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839786
2.
Structural and Ultrastructural Analysis of the Multiple Myeloma Cell Niche and a Patient-Specific Model of Plasma Cell Dysfunction.
Microsc Microanal
; 28(1): 254-264, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34881690
3.
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(11): 2113-2123, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446198
4.
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
Biol Blood Marrow Transplant
; 24(6): 1119-1124, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29608957
5.
Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial.
Br J Haematol
; 176(3): 412-420, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27982425
6.
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
Br J Haematol
; 165(4): 510-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24579926
7.
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
Transplant Cell Ther
; 27(8): 642-649, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34304802
8.
Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma.
Leuk Lymphoma
; 48(12): 2338-44, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18067008
9.
Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.
Leuk Lymphoma
; 56(3): 645-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25130476